Wednesday 08 April 2020

Update from Hindawi on helping to disseminate research on COVID-19

We have introduced a fast-track workflow for papers submitted on coronavirus/COVID-19 which are suitable for publication. To this end, we have signed up to the Wellcome statement on sharing data and findings related to COVID-19 and fully support the commitments laid out by it.

We have also connected with our colleagues at PLOS to maximize availability of submitted papers via preprint servers such as bioRxiv or medRxiv at point of submission and will ensure our authors consider submitting to relevant PLOS journals if we believe the impact of their work would be better served through a different title. 

We are also working with our colleagues at the Royal Society to ensure any registered reports submitted on COVID-19 are forwarded for consideration in their journal Royal Society Open Science which is better placed to handle these types of submissions. For more information please read this blog by Sarah Greaves, Chief Publisher at Hindawi:

Moreover, to keep our readers and the research community up-to-date, our publishing team have put together a collection of new and previously published articles on coronavirus research and treatment which is regularly updated: 

Note: all of our content is open access and published under a CC-BY licence making it freely available to read and reuse. 

About Hindawi Limited:

Hindawi Limited is one of the world's largest open access publishers with an expansive portfolio of academic research journals across all areas of science and medicine. Each peer-reviewed journal has been developed in partnership with academic researchers, acting as editors, to fit the targeted communities they serve.
Driven by a mission to advance openness in research and placing the researcher at the heart of everything we do, we work with publishers, institutions, and organizations to move towards a more open scholarly ecosystem by investing in the development of open source publishing infrastructure. 

For additional information about Hindawi Limited, see To keep up to date with the latest developments, connect with us on Twitter.


There are no comments. Why not be the first?

Add your comment